Founded in Boston in 1947, Dana-Farber is a principal teaching affiliate of Harvard Medical School and federally designated a Comprehensive Cancer Center that develops and disseminates innovative patient therapies and scientific discoveries throughout the world. Since 1948, the Jimmy Fund has raised millions of dollars through thousands of community efforts to advance Dana-Farber’s lifesaving mission.
Today, the Institute has 4,855 employees and 529 faculty members supporting 346,805 outpatient visits a year. The Institute is involved in some 1,100 clinical trials, and is internationally renowned for its blending of research and clinical excellence. The Institute’s expertise in these two aspects of the fight against cancer uniquely positions it to develop and test the next generation of cancer therapies in both the laboratory and the clinic.
Dana-Farber Cancer Institute is a principal teaching affiliate of Harvard Medical School, a federally designated Center for AIDS Research, and a founding member of the Dana-Farber/Harvard Cancer Center, a federally designated comprehensive cancer center.
Dana-Farber/Brigham and Women’s Cancer Center has been ranked by U.S. News & World Report as the best for cancer care in New England for the 19th straight year. This year, Dana-Farber/Brigham and Women’s Cancer Center is ranked #5 in the nation.